5LHQ
The EGR-cmk active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody Nb7
Summary for 5LHQ
Entry DOI | 10.2210/pdb5lhq/pdb |
Related PRD ID | PRD_000288 |
Descriptor | Urokinase-type plasminogen activator, Camelid-Derived Antibody Fragment Nb7, L-alpha-glutamyl-N-{(1S)-4-{[amino(iminio)methyl]amino}-1-[(1S)-2-chloro-1-hydroxyethyl]butyl}glycinamide, ... (6 entities in total) |
Functional Keywords | trypsin-like serine proteases, nanobody, inhibitor, hydrolase-antibody complex, hydrolase/antibody |
Biological source | Mus musculus (House Mouse) More |
Total number of polymer chains | 2 |
Total formula weight | 45434.78 |
Authors | Kromann-Hansen, T.,Lange, E.L.,Sorensen, H.P.,Ghassabeh, G.H.,Huang, M.,Jensen, J.K.,Muyldermans, S.,Declerck, P.J.,Andreasen, P.A. (deposition date: 2016-07-12, release date: 2017-06-28, Last modification date: 2024-01-10) |
Primary citation | Kromann-Hansen, T.,Louise Lange, E.,Peter Srensen, H.,Hassanzadeh-Ghassabeh, G.,Huang, M.,Jensen, J.K.,Muyldermans, S.,Declerck, P.J.,Komives, E.A.,Andreasen, P.A. Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator. Sci Rep, 7:3385-3385, 2017 Cited by PubMed: 28611361DOI: 10.1038/s41598-017-03457-7 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.6 Å) |
Structure validation
Download full validation report